Skip to main content
Top

2013 | OriginalPaper | Hoofdstuk

29. Rheumatic Fever and Valvular Heart Disease

Auteurs : Blanche J. Cupido, MB, ChB, FCP (SA), Patrick J. Commerford, MB, ChB, FCP (SA), FACC

Gepubliceerd in: Essential Cardiology

Uitgeverij: Springer New York

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Although the incidence of rheumatic fever has declined dramatically in developed countries in the last few decades, it continues to be a major cause of morbidity and mortality in the developing world. There is no test specific for the diagnosis in rheumatic fever, and the diagnosis relies heavily on clinical findings and a few simple investigations.
Those with a history of or established rheumatic fever are at increased risk of recurrence, and thus, a lower threshold for the diagnosis of recurrence has been established. Secondary prophylaxis has proven to be the most cost-effective strategy for the prevention of recurrence. Especially in high-risk settings and in more severe valvular heart disease, a longer period, in some cases even lifelong, of prophylaxis is advocated according to the new WHO guidelines.
Mitral stenosis is almost exclusively due to rheumatic heart disease. Medical management, percutaneous balloon valvuloplasty, and valve replacement strategies are discussed. Pure MR is uncommon in rheumatic heart disease. Mitral valve repair or replacement is indicated in patients with severe MR and NYHA III or IV. Asymptomatic or mildly symptomatic patients can be managed medically provided LVEF and symptoms get monitored, and they are referred for surgery if the EF falls toward 60 % or the end-systolic dimension reaches 45 mm.
Aortic stenosis requires surgery when symptoms occur. Patients with severe aortic regurgitation should also be offered valve replacement when they become symptomatic. Those with severe AR who do not experience symptoms require careful evaluation and follow-up of their left ventricular ejection fractions and end-systolic and end-diastolic diameters to determine when surgery would be warranted.
Tricuspid disease is often overlooked as the symptoms of the left-sided lesion may predominate. It is almost always associated with mitral valve disease and adds a dimension of complexity to the treatment as well as an unfavorable impact on prognosis.
In many cases multiple valves are involved, and this has a profound impact on the assessment, by any modality, of the severity of each individual valve lesion.
Literatuur
1.
go back to reference Sliwa K et al. Incidence and characteristics of newly diagnosed RHD in urban African adults: insights from the heart of Soweto study. Eur Heart J. 2010;31:719–27.CrossRefPubMed Sliwa K et al. Incidence and characteristics of newly diagnosed RHD in urban African adults: insights from the heart of Soweto study. Eur Heart J. 2010;31:719–27.CrossRefPubMed
2.
go back to reference Marijon E et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357(5):470–6.CrossRefPubMed Marijon E et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357(5):470–6.CrossRefPubMed
3.
go back to reference Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population. 1. Factors related to the attack rate of rheumatic fever. N Engl J Med. 1961;265:559–65.CrossRef Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population. 1. Factors related to the attack rate of rheumatic fever. N Engl J Med. 1961;265:559–65.CrossRef
4.
go back to reference Dale JB, Beachey EH. Sequence of myosin cross-reactive epitopes of streptococcal M protein. J Exp Med. 1986;164:1785–90.CrossRefPubMed Dale JB, Beachey EH. Sequence of myosin cross-reactive epitopes of streptococcal M protein. J Exp Med. 1986;164:1785–90.CrossRefPubMed
5.
go back to reference Haffejee I. Rheumatic fever and rheumatic heart disease: the current state of its immunology, diagnostic criteria and prophylaxis. Q J Med. 1992;84:641–58.PubMed Haffejee I. Rheumatic fever and rheumatic heart disease: the current state of its immunology, diagnostic criteria and prophylaxis. Q J Med. 1992;84:641–58.PubMed
7.
go back to reference Dajani AS, Ayoub EM, Bierman FZ, et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992. JAMA. 1992;268:2069–73.CrossRef Dajani AS, Ayoub EM, Bierman FZ, et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992. JAMA. 1992;268:2069–73.CrossRef
9.
go back to reference Dajani AS. Current status of nonsuppurative complications of group A streptococci. Pediatr Infect Dis J. 1991;10:S25–7.CrossRefPubMed Dajani AS. Current status of nonsuppurative complications of group A streptococci. Pediatr Infect Dis J. 1991;10:S25–7.CrossRefPubMed
10.
go back to reference 2002–2003 Criteria for recurrent rheumatic fever. WHO: Rheumatic fever and Rheumatic heart disease: report of a WHO expert consultation. Geneva: WHO; 2004. 2002–2003 Criteria for recurrent rheumatic fever. WHO: Rheumatic fever and Rheumatic heart disease: report of a WHO expert consultation. Geneva: WHO; 2004.
11.
go back to reference Haskes PJ et al. Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomised control trial. J Pediatr. 2003;143:300–401. Haskes PJ et al. Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomised control trial. J Pediatr. 2003;143:300–401.
12.
go back to reference Albert DA, Harel L, Karrison T. The treatment of rheumatic carditis: a review and meta-analysis. Medicine (Baltimore). 1995;74:1–12.CrossRef Albert DA, Harel L, Karrison T. The treatment of rheumatic carditis: a review and meta-analysis. Medicine (Baltimore). 1995;74:1–12.CrossRef
13.
go back to reference Cilliers AM, et al. Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst Rev. 2003;(2):CD003176. Cilliers AM, et al. Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst Rev. 2003;(2):CD003176.
14.
go back to reference Lewis BS, Geft IL, Milo S, Gotsman MS. Echocardiography and valve replacement in the critically ill patient with acute rheumatic carditis. Ann Thorac Surg. 1979;27:529–35.CrossRefPubMed Lewis BS, Geft IL, Milo S, Gotsman MS. Echocardiography and valve replacement in the critically ill patient with acute rheumatic carditis. Ann Thorac Surg. 1979;27:529–35.CrossRefPubMed
15.
go back to reference WHO technical report series. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation. Geneva. 29 Oct–1 Nov 2001. WHO technical report series. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation. Geneva. 29 Oct–1 Nov 2001.
16.
go back to reference Lue HC, Wu MH, Wang JK, et al. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks. J Pediatr. 1994;125:812–6.CrossRefPubMed Lue HC, Wu MH, Wang JK, et al. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks. J Pediatr. 1994;125:812–6.CrossRefPubMed
17.
go back to reference Hu MC, Walls MA, Stroop SD, et al. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun. 2002;70:2171–7.CrossRefPubMed Hu MC, Walls MA, Stroop SD, et al. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun. 2002;70:2171–7.CrossRefPubMed
18.
go back to reference Olson LJ, Subramanian R, Ackermann DM, et al. Surgical pathology of the mitral valve. A study of 712 cases spanning 21 years. Mayo Clin Proc. 1987;62:22–34.CrossRefPubMed Olson LJ, Subramanian R, Ackermann DM, et al. Surgical pathology of the mitral valve. A study of 712 cases spanning 21 years. Mayo Clin Proc. 1987;62:22–34.CrossRefPubMed
19.
go back to reference Leavitt JI, Coats MH, Falk RH. Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve. A Doppler echocardiographic study. J Am Coll Cardiol. 1991;17:1520–6.CrossRefPubMed Leavitt JI, Coats MH, Falk RH. Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve. A Doppler echocardiographic study. J Am Coll Cardiol. 1991;17:1520–6.CrossRefPubMed
20.
go back to reference Ohmichi M, Tagaki S, Nomura N, et al. Endobronchial changes in chronic pulmonary venous hypertension. Chest. 1988;94:1127–32.CrossRefPubMed Ohmichi M, Tagaki S, Nomura N, et al. Endobronchial changes in chronic pulmonary venous hypertension. Chest. 1988;94:1127–32.CrossRefPubMed
21.
go back to reference Barrington WW, Boudoulas J, Bashore T, et al. Mitral stenosis: mitral dome excursion at M1 and the mitral opening snap—the concept of reciprocal heart sounds. Am Heart J. 1998;115:1280–90.CrossRef Barrington WW, Boudoulas J, Bashore T, et al. Mitral stenosis: mitral dome excursion at M1 and the mitral opening snap—the concept of reciprocal heart sounds. Am Heart J. 1998;115:1280–90.CrossRef
22.
go back to reference Chiang CW et al. Predictors of systemic embolism in patients with mitral stenosis. A prospective study. Ann Intern Med. 1998;128:885.CrossRefPubMed Chiang CW et al. Predictors of systemic embolism in patients with mitral stenosis. A prospective study. Ann Intern Med. 1998;128:885.CrossRefPubMed
23.
go back to reference Salem DN et al. American College of Chest Physicians Evidenced-based Clinical Practice Guidelines 8th edition. Valvular and structural heart disease. Chest. 2008;133:593S–629.CrossRefPubMed Salem DN et al. American College of Chest Physicians Evidenced-based Clinical Practice Guidelines 8th edition. Valvular and structural heart disease. Chest. 2008;133:593S–629.CrossRefPubMed
24.
go back to reference Klein HO, Sareli P, Schamroth CL, et al. Effects of atenolol on exercise capacity in patients with mitral stenosis with sinus rhythm. Am J Cardiol. 1985;56:598–601.CrossRefPubMed Klein HO, Sareli P, Schamroth CL, et al. Effects of atenolol on exercise capacity in patients with mitral stenosis with sinus rhythm. Am J Cardiol. 1985;56:598–601.CrossRefPubMed
25.
go back to reference Stoll BC et al. Effects of atenolol on rest and exercise haemodynamics in patients with mitral stenosis. Am J Cardiol. 1995;75:482.CrossRefPubMed Stoll BC et al. Effects of atenolol on rest and exercise haemodynamics in patients with mitral stenosis. Am J Cardiol. 1995;75:482.CrossRefPubMed
26.
go back to reference Bonow RO, Carabello B, de Leon Jr AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation. 2006;114:e84–231.CrossRefPubMed Bonow RO, Carabello B, de Leon Jr AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation. 2006;114:e84–231.CrossRefPubMed
27.
go back to reference Marcus RH, Sareli P, Pocock WA, Barlow JB. The spectrum of severe rheumatic mitral valve disease in a developing country: correlations among clinical presentations, surgical pathologic finding and haemodynamic sequelae. Ann Intern Med. 1994;120:177–83.CrossRefPubMed Marcus RH, Sareli P, Pocock WA, Barlow JB. The spectrum of severe rheumatic mitral valve disease in a developing country: correlations among clinical presentations, surgical pathologic finding and haemodynamic sequelae. Ann Intern Med. 1994;120:177–83.CrossRefPubMed
29.
30.
go back to reference Passik CS, Ackermann DM, Pluth JR, Edwards WP. Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. Mayo Clin Proc. 1987;62:119–23.CrossRefPubMed Passik CS, Ackermann DM, Pluth JR, Edwards WP. Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. Mayo Clin Proc. 1987;62:119–23.CrossRefPubMed
31.
go back to reference Levinson GE. Aortic stenosis. In: Dalen JE, Alpert JS, editors. Valvular heart disease. 2nd ed. Boston: Little, Brown; 1987. p. 202–3. Levinson GE. Aortic stenosis. In: Dalen JE, Alpert JS, editors. Valvular heart disease. 2nd ed. Boston: Little, Brown; 1987. p. 202–3.
32.
go back to reference Zitnik RS, Piemme TE, Messer RJ, et al. The masking of aortic stenosis by mitral stenosis. Am Heart J. 1965;69:22–30.CrossRefPubMed Zitnik RS, Piemme TE, Messer RJ, et al. The masking of aortic stenosis by mitral stenosis. Am Heart J. 1965;69:22–30.CrossRefPubMed
33.
go back to reference Ross Jr J, Braunwald E. Aortic stenosis. Circulation. 1968;38(Suppl V):V-61–7.CrossRef Ross Jr J, Braunwald E. Aortic stenosis. Circulation. 1968;38(Suppl V):V-61–7.CrossRef
34.
go back to reference Lancellotti P et al. Clinical outcome in asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2012;59:235–43.CrossRefPubMed Lancellotti P et al. Clinical outcome in asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2012;59:235–43.CrossRefPubMed
35.
go back to reference Flachskampf FA et al. Varying haemodynamics and differences in prognosis in patients with asymptomatic severe aortic stenosis and preserved ejection function: a call to review cutoffs and concepts. J Am Coll Cardiol. 2012;59:244–5.CrossRefPubMed Flachskampf FA et al. Varying haemodynamics and differences in prognosis in patients with asymptomatic severe aortic stenosis and preserved ejection function: a call to review cutoffs and concepts. J Am Coll Cardiol. 2012;59:244–5.CrossRefPubMed
36.
go back to reference Awtry E, Davidhoff R, et al. Low flow/low gradient aortic stenosis. Circulation. 2011;124:e739–41.CrossRefPubMed Awtry E, Davidhoff R, et al. Low flow/low gradient aortic stenosis. Circulation. 2011;124:e739–41.CrossRefPubMed
37.
go back to reference Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med. 1994;331:689–94.CrossRefPubMed Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med. 1994;331:689–94.CrossRefPubMed
38.
go back to reference Rahimtoola SH. Indications for surgery in aortic valve disease. In: Yusuf S, Cairns JA, Camm AJ, editors. Evidence based cardiology. London: BMJ Books; 1998. p. 811–32. Rahimtoola SH. Indications for surgery in aortic valve disease. In: Yusuf S, Cairns JA, Camm AJ, editors. Evidence based cardiology. London: BMJ Books; 1998. p. 811–32.
39.
go back to reference Braunwald E. Valvular heart disease. In: Braunwald EB, editor. Heart disease: a textbook of cardiovascular medicine. 5th ed. Philadelphia: W. B. Saunders; 1997. p. 1007–76. Braunwald E. Valvular heart disease. In: Braunwald EB, editor. Heart disease: a textbook of cardiovascular medicine. 5th ed. Philadelphia: W. B. Saunders; 1997. p. 1007–76.
40.
go back to reference Unger P, Rosenhek R, Deeobbeleer A, et al. Management of multiple valve disease. Heart. 2011;97:272–7.CrossRefPubMed Unger P, Rosenhek R, Deeobbeleer A, et al. Management of multiple valve disease. Heart. 2011;97:272–7.CrossRefPubMed
go back to reference Carabello BA. Mitral valve disease: indications for surgery. In: Yusuf S, Cairns JA, Camm AJ, editors. Evidence based cardiology. London: BMJ Books; 2003. p. 758–66. Carabello BA. Mitral valve disease: indications for surgery. In: Yusuf S, Cairns JA, Camm AJ, editors. Evidence based cardiology. London: BMJ Books; 2003. p. 758–66.
go back to reference Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Pediatrics. 1995;96:758–64.PubMed Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Pediatrics. 1995;96:758–64.PubMed
go back to reference Otto CM, Burwask IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95:2262–70.CrossRefPubMed Otto CM, Burwask IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95:2262–70.CrossRefPubMed
go back to reference Turi ZG. Balloon valvuloplasty: mitral valve. In: Yusuf S, Cairns JA, Camm AJ, editors. Evidence based cardiology. London: BMJ Books; 2003. p. 796–808. Turi ZG. Balloon valvuloplasty: mitral valve. In: Yusuf S, Cairns JA, Camm AJ, editors. Evidence based cardiology. London: BMJ Books; 2003. p. 796–808.
Metagegevens
Titel
Rheumatic Fever and Valvular Heart Disease
Auteurs
Blanche J. Cupido, MB, ChB, FCP (SA)
Patrick J. Commerford, MB, ChB, FCP (SA), FACC
Copyright
2013
Uitgeverij
Springer New York
DOI
https://doi.org/10.1007/978-1-4614-6705-2_29